Actively Recruiting

Age: 18Years +
FEMALE
ID06794190

Characterization of Liver Problems in Turner Syndrome Observational Study of Causes and Liver Assessments

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-27

120

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to explore the frequency and causes of liver changes in adult women diagnosed with Turner Syndrome (TS). The study focuses on identifying biochemical and structural liver abnormalities and understanding the factors that may contribute to liver disease in this population. By investigating these aspects, the study hopes to provide important insights into the development and prognosis of liver problems in TS patients. The study is observational and retrospective, involving adult women with TS who are being monitored over time at the Endocrinology and Diabetes Prevention and Care unit of IRCCS Policlinico S. Orsola in Bologna. Diagnosis of TS was confirmed by karyotype analysis of peripheral blood, typically performed during childhood or adulthood at specialized centers. Participants undergo clinical evaluations including measurement of body parameters, and detailed medical history reviews focusing on metabolic and autoimmune conditions, menstrual cycle history, and hormone replacement therapies. Laboratory tests related to liver function are also conducted as part of the routine clinical assessment. Participants will be involved through ongoing monitoring of their clinical and laboratory data as part of standard care. Researchers will review medical histories and collect data on liver function and related factors to identify any associations with liver disease in TS. The primary outcome measure is factors associated with liver disease at baseline. The study aims to generate new hypotheses about liver disease development and progression in women with Turner Syndrome, contributing valuable etiologic and prognostic information.

CONDITIONS

Official Title

Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Turner syndrome made by karyotype analysis on peripheral blood.
  • Age 18 years or older
  • Written informed consent obtained
Not Eligible

You will not qualify if you...

  • TS patients on therapy with drugs responsible for significant liver enzyme alterations (liver function alteration, LFA).

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy, 40138

Actively Recruiting

Loading map...

Research Team

A

Alessandra Gambineri, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Bleeding Patterns in Sequential and Continuous Progesterone ...

Turner Syndrome

Actively Recruiting

1 location

Cardiopulmonary Exercise Testing in Girls Aged 8 to 18 with ...

Turner Syndrome

Actively Recruiting

1 location

Determining Dose Equivalence Between Oral and Transdermal Es...

Turner Syndrome

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here